Related Experiment Video
Updated: Jun 21, 2026
09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Cognitive functioning in Alzheimer's and vascular dementia: a meta-analysis
1School of Psychology, University of Adelaide, Adelaide, Australia. psyj-mat@complex.psych.adelaide.edu.au
Neuropsychology
|July 10, 2009
Summary
Distinguishing Alzheimer's disease (AD) from vascular dementia (VaD) is crucial for treatment. While some cognitive tests show differences, none are definitive for diagnosing AD versus VaD.
Area of Science:
- Neuroscience
- Neurology
- Cognitive Psychology
Background:
- Differentiating Alzheimer's disease (AD) and vascular dementia (VaD) is clinically significant for targeted treatment.
- Cognitive assessments are vital for dementia diagnosis, yet specific tests distinguishing AD from VaD lack clear evidence.
- Existing pharmacological treatments for AD and VaD require accurate differential diagnosis for efficacy.
Purpose of the Study:
- To conduct a meta-analysis of studies comparing cognitive abilities in individuals diagnosed with AD and VaD.
- To identify specific cognitive tests that best discriminate between AD and VaD.
- To evaluate the overall utility of cognitive assessments in differentiating these two dementia types.
Main Methods:
- A systematic literature search was performed using PubMed and PsychInfo databases.
- Eighty-one studies comparing cognitive performance in AD and VaD patients were included in the meta-analysis.
- Statistical analyses included weighted Cohen's d effect sizes, percentage overlap, fail-safe Ns, and confidence intervals for cognitive tests.
Main Results:
- One perceptual test and one verbal memory test demonstrated large, significant group differences between AD and VaD.
- An additional 12 cognitive tests showed potential utility in distinguishing between the two conditions.
- Despite these findings, all examined cognitive tests exhibited limited discriminatory power between AD and VaD.
Conclusions:
- Cognitive tests alone have limited ability to definitively differentiate between Alzheimer's disease and vascular dementia.
- Specific tests of perception and verbal memory show promise but require cautious interpretation.
- Differential diagnosis of AD and VaD should integrate cognitive data with other clinical information, such as neuroimaging and medical history.
More Related Videos
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...